Asian Pacific Journal of Cancer Prevention

Asian Pacific Journal of Cancer Prevention (아시아태평양암예방학회)
권호 표지
DOI QR코드

DOI QR Code

P53 and PCNA is Positively Correlated with HPV Infection in Laryngeal Epitheliopapillomatous Lesions in Patiets with Different Ethnic Backgrounds in Xinjiang

  • Sun, Jie (Department of ENT, the First Affiliated Hospital of Xinjiang Medical University) ;
  • Xiong, Ju (Department of General Surgery, the People's Hospital of Xinjiang Uygur Autonomous Region) ;
  • Zhen, Yan (Department of ENT, the Second Affiliated Hospital of Xinjiang Medical University) ;
  • Chen, Zhao-Lun (Department of ENT, the First Affiliated Hospital of Xinjiang Medical University) ;
  • Zhang, Hua (Department of ENT, the First Affiliated Hospital of Xinjiang Medical University)
  • Published : 2012.11.30
Download PDF
⟨ Previous Next ⟩

Abstract

Objective: To explore the correlation of human papillomavious (HPV) infection with expression of p53 and proliferating cell nuclear antigen (PCNA) in patients with different ethnicity in Xinjiang, China. Methods: 166 biopsy specimens from 83 laryngeal squamous cell carcinomas (LSCC), 63 laryngeal papillomas (LP), and 20 laryngeal inflammatory polyps (LIP) were included in this study. HPV infection was determined by polymerase chain reaction (PCR) using specific types of HPV primers. Expression of p53 and PCNA was assessed using immunohistostaining. Results: The frequency of HPV 6/11 was higher in LP (33.3%) than in LSCC (9.6%) (P<0.0005), whereas the frequency of HPV 16/18 was higher in LSCC (37.3 %) than in LP (6.3%) (P<0.0005). Patients of the Han ethnic group with LSCC had a higher infection rate with HPV 6/11 or HPV 6/11 and HPV 16/18 coinfection than those of Uygur and Kazak ethnicity (P<0.05). Overexpression of p53 and PCNA were higher in LSCC (62.7%, 57.8%) than in LP (38%, 33.3%) (P<0.005, and P<0.005, respectively). That of p53 was not associated with lymph-node metastases and clinical stages, but overexpression of PCNA closely correlated with clinical stage. Conclusions: These results strongly implicate HPV6/11 infection in the carcinogenesis of LSCC and LP, respectively. There was a higher coincidence of increased malignancy of laryngeal tumors with overexpression of p53 and PCNA. Overexpression of p53 may serve as an early risk marker for malignant transformation in HPV infected cells while the overexpression of PCNA may serve as a late marker for progression of LSCC.

Keywords

References

  1. Almadori G, Cadoni G, Cattani P, et al (2001). Human papillomavirus infection and epidermal growth factor receptor expression in primary laryngeal squamous cell carcinoma. Clin Cancer Res, 7, 3988-93.
  2. Azzimonti B, Pagano M, Mondini M, et al (2004). Altered patterns of the interferon-inducible gene IFI16 expression in head and neck squamous cell carcinoma: immunohistochemical study including correlation with retinoblastoma protein, human papillomavirus infection and proliferation index. Histopathology, 45, 560-72. https://doi.org/10.1111/j.1365-2559.2004.02000.x
  3. Demeter LM, Stoler MH, Broker TR, Chow LT (1994). Induction of proliferating cell nuclear antigen in differentiated keratinocytes of human papillomavirus-infected lesions. Hum Pathol, 25, 343-8. https://doi.org/10.1016/0046-8177(94)90141-4
  4. Dong Y, Sui L, Tai Y, et al (2000). Prognostic significance of cyclin E overexpression in laryngeal squamous cell carcinomas. Clin Cancer Res, 6, 4253-8.
  5. Du J, Chen GG, Vlantis AC, et al (2003). The nuclear localization of NFkappaB and p53 is positively correlated with HPV16 E7 level in laryngeal squamous cell carcinoma. J Histochem Cytochem, 51, 533-9. https://doi.org/10.1177/002215540305100415
  6. El-Naggar AK, Westra WH (2012). p16 expression as a surrogate marker for HPV-related oropharyngeal carcinoma: a guide for interpretative relevance and consistency. Head Neck, 34, 459-61. https://doi.org/10.1002/hed.21974
  7. Fakhry C, Westra WH, Li S, et al (2008). Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst, 100, 261-9. https://doi.org/10.1093/jnci/djn011
  8. Freedman DA, Levine AJ (1998). Nuclear export is required for degradation of endogenous p53 by MDM2 and human papillomavirus E6. Mol Cell Biol, 18, 7288-93. https://doi.org/10.1128/MCB.18.12.7288
  9. Gao Y, Ferguson DO, Xie W, et al (2000). Interplay of p53 and DNA-repair protein XRCC4 in tumorigenesis, genomic stability and development. Nature, 404, 897-900. https://doi.org/10.1038/35009138
  10. Grace Nirmala J, Narendhirakannan RT (2011). Detection and genotyping of high-risk HPV and evaluation of anti-oxidant status in cervical carcinoma patients in Tamil Nadu State, India--a case control study. Asian Pac J Cancer Prev, 12, 2689-95.
  11. Hall SF, Groome PA, Irish J, O'Sullivan B (2009). TNM-based stage groupings in head and neck cancer: application in cancer of the hypopharynx. Head Neck, 31, 1-8. https://doi.org/10.1002/hed.20917
  12. Horibe Y, Murakami M, Komori K, Imaeda Y, Kasahara M (2000). Expression of topoisomerase II alpha, Ki-67 and p53 in early stage laryngeal carcinomas not featuring vocal cord fixation. Apmis, 108, 689-96. https://doi.org/10.1034/j.1600-0463.2000.d01-16.x
  13. Ji W, Guan C, Pan Z (2008). Analysis of curative effects on laryngeal carcinoma patients in the northeast region of China. Acta Otolaryngol, 128, 574-7. https://doi.org/10.1080/00016480701596104
  14. Koskinen WJ, Brondbo K, Mellin Dahlstrand H, et al (2007). Alcohol, smoking and human papillomavirus in laryngeal carcinoma: a Nordic prospective multicenter study. J Cancer Res Clin Oncol, 133, 673-8. https://doi.org/10.1007/s00432-007-0219-8
  15. Krecicki T, Jelen M, Zalesska-Krecicka M, et al (1999). Epidermal growth factor receptor (EGFR), proliferating cell nuclear antigen (PCNA) and Ki-67 antigen in laryngeal epithelial lesions. Oral Oncol, 35, 180-6. https://doi.org/10.1016/S1368-8375(98)00100-6
  16. Kumar RV, Shenoy AM, Daniel R, Shah KV (2004). Cyclin D1, p53, MIB1, intratumoral microvessel density, and human papillomavirus in advanced laryngeal carcinoma: association with nodal metastasis. Otolaryngol Head Neck Surg, 131, 509-13. https://doi.org/10.1016/j.otohns.2004.03.029
  17. Lin HP, Wang YP, Chiang CP (2011). Expression of p53, MDM2, p21, heat shock protein 70, and HPV 16/18 E6 proteins in oral verrucous carcinoma and oral verrucous hyperplasia. Head Neck, 33, 334-40.
  18. Liu M, Lawson G, Delos M, et al (2003). Prognostic value of cell proliferation markers, tumour suppressor proteins and cell adhesion molecules in primary squamous cell carcinoma of the larynx and hypopharynx. Eur Arch Otorhinolaryngol, 260, 28-34.
  19. Mantovani F, Banks L (2001). The human papillomavirus E6 protein and its contribution to malignant progression. Oncogene, 20, 7874-87. https://doi.org/10.1038/sj.onc.1204869
  20. Marioni G, Marchese-Ragona R, Cartei G, Marchese F, Staffieri A (2006). Current opinion in diagnosis and treatment of laryngeal carcinoma. Cancer Treat Rev, 32, 504-15. https://doi.org/10.1016/j.ctrv.2006.07.002
  21. Marur S, Forastiere AA (2008). Head and neck cancer: changing epidemiology, diagnosis, and treatment. Mayo Clin Proc, 83, 489-501. https://doi.org/10.4065/83.4.489
  22. Maxwell SA, Davis GE (2000). Differential gene expression in p53-mediated apoptosis-resistant vs. apoptosis-sensitive tumor cell lines. Proc Natl Acad Sci USA, 97, 13009-14. https://doi.org/10.1073/pnas.230445997
  23. Micozkadioglu D, Unal M, Pata YS, Basturk M, Cinel L (2008). Prognostic value of expression of p53, proliferating cell nuclear antigen, and c-erbB-2 in laryngeal carcinoma. Med Sci Monit, 14, CR299-304.
  24. Munck-Wikland E, Edstrom S, Jungmark E, et al (1994). Nuclear DNA content, proliferating-cell nuclear antigen (PCNA) and p53 immunostaining in predicting progression of laryngeal cancer in situ lesions. Int J Cancer, 56, 95-9.
  25. Munger K, Howley PM (2002). Human papillomavirus immortalization and transformation functions. Virus Res, 89, 213-28. https://doi.org/10.1016/S0168-1702(02)00190-9
  26. Nakagawa S, Huibregtse JM (2000). Human scribble (Vartul) is targeted for ubiquitin-mediated degradation by the high-risk papillomavirus E6 proteins and the E6AP ubiquitin-protein ligase. Mol Cell Biol, 20, 8244-53. https://doi.org/10.1128/MCB.20.21.8244-8253.2000
  27. Park JS, Kim EJ, Lee JY, et al (2001). Functional inactivation of p73, a homolog of p53 tumor suppressor protein, by human papillomavirus E6 proteins. Int J Cancer, 91, 822-7. https://doi.org/10.1002/1097-0215(200002)9999:9999<::AID-IJC1130>3.0.CO;2-0
  28. Parkin DM, Bray F, Ferlay J, Pisani P (2001). Estimating the world cancer burden: Globocan 2000. Int J Cancer, 94, 153-6. https://doi.org/10.1002/ijc.1440
  29. Parkin DM, Bray F, Ferlay J, Pisani P (2005). Global cancer statistics, 2002. CA Cancer J Clin, 55, 74-108. https://doi.org/10.3322/canjclin.55.2.74
  30. Pruneri G, Pignataro L, Carboni N, et al (1997). MDM-2 oncoprotein overexpression in laryngeal squamous cell carcinoma: association with wild-type p53 accumulation. Mod Pathol, 10, 785-92.
  31. Raybaud-Diogene H, Tetu B, Morency R, Fortin A, Monteil RA (1996). p53 overexpression in head and neck squamous cell carcinoma: review of the literature. Eur J Cancer B Oral Oncol, 32B, 143-9.
  32. Sarafoleanu D, Postelnicu V, Iosif C, Manea C, Sarafoleanu C (2009). The role of p53, PCNA and Ki-67 as outcome predictors in the treatment of laryngeal cancer. J Med Life, 2, 219-26.
  33. Scheffner M, Huibregtse JM, Vierstra RD, Howley PM (1993). The HPV-16 E6 and E6-AP complex functions as a ubiquitinprotein ligase in the ubiquitination of p53. Cell, 75, 495-505. https://doi.org/10.1016/0092-8674(93)90384-3
  34. Schena M, Shalon D, Davis RW, Brown PO (1995). Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science, 270, 467-70. https://doi.org/10.1126/science.270.5235.467
  35. Stasikowska-Kanicka O, Wagrowska-Danilewicz M, Danilewicz M (2011). Effect of human papillomavirus on cell cyclerelated proteins p16INK4A, p21waf1/cip1, p53 and cyclin D1 in sinonasal inverted papilloma and laryngeal carcinoma. An in situ hybridization study. Folia Histochem Cytobiol, 49, 34-40. https://doi.org/10.5603/FHC.2011.0006
  36. Storey A, Thomas M, Kalita A, et al (1998). Role of a p53 polymorphism in the development of human papillomavirusassociated cancer. Nature, 393, 229-34. https://doi.org/10.1038/30400
  37. Subler MA, Martin DW, Deb S (1992). Inhibition of viral and cellular promoters by human wild-type p53. J Virol, 66, 4757-62.
  38. Tang N, Huang S, Erickson B, et al (2009). High-risk HPV detection and concurrent HPV 16 and 18 typing with Abbott RealTime High Risk HPV test. J Clin Virol, 45, S25-8. https://doi.org/10.1016/S1386-6532(09)70005-8
  39. Wittekindt C, Wagner S, Mayer CS, Klussmann JP (2012). Basics of tumor development and importance of human papilloma virus (HPV) for head and neck cancer. Laryngorhinootologie, 91, S1-26. https://doi.org/10.1055/s-0031-1297241
  40. Xie M, Xiao J, Tao Z, Luo J (1997). A preliminary study on p53 gene expression and infection of human papilloma virus in laryngeal squamous cell carcinoma. Hunan Yi Ke Da Xue Xue Bao, 22, 209-11.
  41. Yao CD (1992). Detection of HPV-16-related DNA sequence in laryngeal squamous cell carcinoma. Zhonghua Er Bi Yan Hou Ke Za Zhi, 27, 241-56.
  42. zur Hausen H (2002). Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer, 2, 342-50. https://doi.org/10.1038/nrc798

Cited by

  1. Detection of human papillomavirus in laryngeal squamous cell carcinoma: Systematic review and meta-analysis vol.126, pp.4, 2015, https://doi.org/10.1002/lary.25738